Why the study?
Does the analysis of Irisin, ZAG and Betatrophin improve accuracy in diagnosing PCOS compared to using a single cytokine?
Does the analysis of Irisin, ZAG and Betatrophin improve accuracy in diagnosing PCOS compared to using a single cytokine?
A combination of Irisin, ZAG, and Betatrophin improves diagnostic accuracy for PCOS over single cytokine analysis.
May improve PCOS diagnostic accuracy; leaves open prospective validation before clinical adoption.
When compared to using single cytokine, the analysis of Irisin, ZAG and Betatrophin elevates the accuracy in diagnosing PCOS.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: